entertainment -WSS

entertainment

author：knowledge 2025-08-28 02:51:20 - browse：432

A photo of Robert Blum speaking at the STAT Summit West on May 16, 2024 — Cytokinetics CEO Robert Blum spoke last week at a talk during STAT’s Breakthrough Summit West in San Francisco. Sarah Gonzalez for STAT

Cytokinetics, a drugmaker that is expected to soon launch a promising new heart therapy called aficamten, said Wednesday that it had agreed to pay biotech firm Royalty Pharma a higher royalty on the medicine in return for up to $575 million, which will be used to fund the marketing of the drug and Cytokinetics’ ongoing research and development efforts.

Cytokinetics shares fell nearly 10% in after-hours trading after the announcement, which investors viewed as lowering the odds that the company will be purchased by a larger pharmaceutical company.

The firm also said that it would be raising $500 million through a stock sale.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Heart attack and stroke risk calculators need revising
Next article： A public health expert passes on football's full body collisions for youths

WSS

FDA approves first new drug developed for postpartum depression

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Over 1,300 arrested in France in 4th night of protests over fatal police shooting of teen Nahel M.

N.Y. state detects polio case, first in the U.S. since 2013

Palantir health business leans on meeting customers’ needs

The thinking behind the controversial eating disorder chatbot Tessa

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

leisure time

ChatGPT in medicine: STAT answers readers' burning questions

What to know about OceanGate, the company behind the missing Titanic submersible

Sports medicine is finally prioritizing gender equality

Biogen nominates mother of director’s child to replace him on board

Medical records are filled with copy

Why 40% Americans with Parkinson’s don’t see a neurologist

Apple is now the first public company to be valued at $3 trillion

Why ADHD is under

ChatGPT in medicine: STAT answers readers' burning questions

Biden launches a new push to limit health care costs

focus

What to know about OceanGate, the company behind the missing Titanic submersible

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Bulgari apologizes to China for listing Taiwan as a country after online backlash

Biden launches a new push to limit health care costs

Eli Lilly’s Mounjaro succeeds in second weight

Eli Lilly’s Mounjaro succeeds in second weight

explore

hotspot

focus

hotspot